{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:41:03Z","timestamp":1792503663393,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Partnership of Native American Cancer Prevention funded by the National Cancer Institute of the National Institutes of Health","award":["U54CA143924"],"award-info":[{"award-number":["U54CA143924"]}]},{"name":"Arizona Biomedical Research Centre Grant","award":["RFGA2022-010\u201318"],"award-info":[{"award-number":["RFGA2022-010\u201318"]}]},{"name":"Flinn Foundation and the Tom and Catherine Culley Charitable Trust Translational Seed Grant","award":["22-06544"],"award-info":[{"award-number":["22-06544"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-05070-w","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:57:06Z","timestamp":1784811426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted lipidomics unveils complex lipids in cervicovaginal environment as diagnostic and prognostic biomarkers for endometrial cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Anita","family":"Garwolinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"\u0141aniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-5917","authenticated-orcid":false,"given":"Melissa M.","family":"Herbst-Kralovetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"5070_CR1","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.3390\/cancers15164101","volume":"15","author":"W Zheng","year":"2023","unstructured":"Zheng W. Molecular classification of endometrial cancer and the 2023 FIGO staging: exploring the challenges and opportunities for pathologists. Cancers (Basel). 2023;15:4101.","journal-title":"Cancers (Basel)"},{"key":"5070_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.21037\/tcr-22-1616","volume":"12","author":"YL Lyu","year":"2023","unstructured":"Lyu YL, Geng L, Wang FX, Yang CL, Rong SJ, Zhou HF, et al. Comparative analysis of pre- and postmenopausal endometrial cancer in 216 patients. Transl Cancer Res. 2023;12:595\u2013604.","journal-title":"Transl Cancer Res"},{"key":"5070_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.890908","volume":"12","author":"K Njoku","year":"2022","unstructured":"Njoku K, Barr CE, Crosbie EJ. Current and emerging prognostic biomarkers in endometrial cancer. Front Oncol. 2022;12:890908.","journal-title":"Front Oncol"},{"key":"5070_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.780769","volume":"12","author":"X Yang","year":"2021","unstructured":"Yang X, Li X, Dong Y, Fan Y, Cheng Y, Zhai L, et al. Effects of metabolic syndrome and its components on the prognosis of endometrial cancer. Front Endocrinol (Lausanne). 2021;12:780769.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5070_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0015-0282(00)00683-X","volume":"74","author":"A Ries","year":"2000","unstructured":"Ries A, Singson P, Bidus M, Barnes JG. Use of the endometrial pipelle in the diagnosis of early abnormal gestations. Fertil Steril. 2000;74:593\u20135.","journal-title":"Fertil Steril"},{"key":"5070_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/bjc.2011.173","volume":"104","author":"N Johnson","year":"2011","unstructured":"Johnson N, Miles T, Bailey D, Tylko-Hill K, Das N, Ahson G, et al. Delays in treating endometrial cancer in the South West of England. Br J Cancer. 2011;104:1836\u20139.","journal-title":"Br J Cancer"},{"key":"5070_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ygyno.2024.01.010","volume":"182","author":"AJ Fife","year":"2024","unstructured":"Fife AJ, Najor AJ, Aspir TB, Haines KE, Vilardo NA, Isani SS, et al. Reduced healthcare access contributes to delay of care in endometrial cancer. Gynecol Oncol. 2024;182:115\u201320.","journal-title":"Gynecol Oncol"},{"key":"5070_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01757-3","volume":"22","author":"Y Shen","year":"2023","unstructured":"Shen Y, Yang W, Liu J, Zhang Y. Minimally invasive approaches for the early detection of endometrial cancer. Mol Cancer. 2023;22:53.","journal-title":"Mol Cancer"},{"key":"5070_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1447-0756.2008.00796.x","volume":"34","author":"P Uharcek","year":"2008","unstructured":"Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res. 2008;34:776\u201383.","journal-title":"J Obstet Gynaecol Res"},{"key":"5070_CR10","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.3390\/cancers13225848","volume":"13","author":"JC Kasius","year":"2021","unstructured":"Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, et al. Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. Cancers (Basel). 2021;13:5848.","journal-title":"Cancers (Basel)"},{"key":"5070_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.101797","volume":"35","author":"V Podder","year":"2025","unstructured":"Podder V, Slomovitz BM. Precision oncology in endometrial cancer: closing the gap between potential and practice. Int J Gynecol Cancer. 2025;35:101797.","journal-title":"Int J Gynecol Cancer"},{"key":"5070_CR12","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/jcm9061900","volume":"9","author":"E Coll-de la Rubia","year":"2020","unstructured":"Coll-de la Rubia E, Martinez-Garcia E, Dittmar G, Gil-Moreno A, Cabrera S, Colas E. Prognostic biomarkers in endometrial cancer: a systematic review and meta-analysis. J Clin Med. 2020;9:1900.","journal-title":"J Clin Med"},{"key":"5070_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep20984","volume":"6","author":"J Li","year":"2016","unstructured":"Li J, Ren S, Piao HL, Wang F, Yin P, Xu C, et al. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer. Sci Rep. 2016;6:20984.","journal-title":"Sci Rep"},{"key":"5070_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1469-5","volume":"15","author":"D de Gonzalo-Calvo","year":"2015","unstructured":"de Gonzalo-Calvo D, L\u00f3pez-Vilar\u00f3 L, Nasarre L, Perez-Olabarria M, V\u00e1zquez T, Escuin D, et al. Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study. BMC Cancer. 2015;15:460.","journal-title":"BMC Cancer"},{"key":"5070_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","volume":"19","author":"S Yue","year":"2014","unstructured":"Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014;19:393\u2013406.","journal-title":"Cell Metab"},{"key":"5070_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41420-025-02325-y","volume":"11","author":"L Ma","year":"2025","unstructured":"Ma L, Huang W, Liang X, Li H, Yu W, Liu L, et al. Inhibition of lanosterol synthase linking with MAPK\/JNK signaling pathway suppresses endometrial cancer. Cell Death Discov. 2025;11:55.","journal-title":"Cell Death Discov"},{"key":"5070_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/ol.2023.13817","volume":"25","author":"VN Ayyagari","year":"2023","unstructured":"Ayyagari VN, Li M, Diaz-Sylvester P, Groesch K, Wilson T, Pasman Z, et al. Evaluation of sterol\u2011o\u2011acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study. Oncol Lett. 2023;25:231.","journal-title":"Oncol Lett"},{"key":"5070_CR18","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00216-023-04586-x","volume":"415","author":"F Cheng","year":"2023","unstructured":"Cheng F, Fan W, Gui L, Liu Y, Ling Y, Huang R, et al. Serum lipidomic profiling by UHPLC-MS\/MS may be able to detect early-stage endometrial cancer. Anal Bioanal Chem. 2023;415:1841\u201354.","journal-title":"Anal Bioanal Chem"},{"key":"5070_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/path.5160","volume":"247","author":"M Cummings","year":"2019","unstructured":"Cummings M, Massey KA, Mappa G, Wilkinson N, Hutson R, Munot S, et al. Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer. J Pathol. 2019;247:21\u201334.","journal-title":"J Pathol"},{"key":"5070_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jsbmb.2018.01.012","volume":"178","author":"T Knific","year":"2018","unstructured":"Knific T, Vouk K, Smrkolj S, Prehn C, Adamski J, Rizner TL. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer. J Steroid Biochem Mol Biol. 2018;178:312\u201321.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5070_CR21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/ijc.33943","volume":"150","author":"X Yan","year":"2022","unstructured":"Yan X, Zhao W, Wei J, Yao Y, Sun G, Wang L, et al. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia. Int J Cancer. 2022;150:1549\u201359.","journal-title":"Int J Cancer"},{"key":"5070_CR22","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1158\/1078-0432.CCR-23-2934","volume":"30","author":"GM Lorentzen","year":"2024","unstructured":"Lorentzen GM, \u0141aniewski P, Cui H, Mahnert ND, Mourad J, Borst MP, et al. Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification. Clin Cancer Res. 2024;30:3073\u201387.","journal-title":"Clin Cancer Res"},{"key":"5070_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00438-5","volume":"10","author":"P \u0141aniewski","year":"2022","unstructured":"\u0141aniewski P, Cui H, Mahnert ND, Mourad J, Borst MP, Willmott L, et al. Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer. Biomark Res. 2022;10:88.","journal-title":"Biomark Res"},{"key":"5070_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25879-7","volume":"8","author":"P \u0141aniewski","year":"2018","unstructured":"\u0141aniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, et al. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 2018;8:7593.","journal-title":"Sci Rep"},{"key":"5070_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00520-025-09533-3","volume":"33","author":"BD Taffe","year":"2025","unstructured":"Taffe BD, Petermann V, Biru BM, Albright BB, Wheeler SB, Bae-Jump VL, et al. \u201cIt really takes a village\u201d: perspectives on multi-level barriers to endometrial cancer care for rural patients. Support Care Cancer. 2025;33:490.","journal-title":"Support Care Cancer"},{"key":"5070_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00958-7","volume":"12","author":"R van den Helder","year":"2020","unstructured":"van den Helder R, Wever BMM, van Trommel NE, van Splunter AP, Mom CH, Kasius JC, et al. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine. Clin Epigenetics. 2020;12:165.","journal-title":"Clin Epigenetics"},{"key":"5070_CR27","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.3390\/jcm13247538","volume":"13","author":"A Asaturova","year":"2024","unstructured":"Asaturova A, Zaretsky A, Rogozhina A, Tregubova A, Badlaeva A. Advancements in minimally invasive techniques and biomarkers for the early detection of endometrial cancer: a comprehensive review of novel diagnostic approaches and clinical implications. J Clin Med. 2024;13:7538.","journal-title":"J Clin Med"},{"key":"5070_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.559016","volume":"10","author":"K Njoku","year":"2020","unstructured":"Njoku K, Chiasserini D, Jones ER, Barr CE, O\u2019Flynn H, Whetton AD, et al. Urinary biomarkers and their potential for the non-invasive detection of endometrial cancer. Front Oncol. 2020;10:559016.","journal-title":"Front Oncol"},{"key":"5070_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109001","volume":"27","author":"J Hedlund Lindberg","year":"2024","unstructured":"Hedlund Lindberg J, Widgren A, Ivansson E, Gustavsson I, Stalberg K, Gyllensten U, et al. Toward ovarian cancer screening with protein biomarkers using dried, self-sampled cervico-vaginal fluid. iScience. 2024;27:109001.","journal-title":"iScience"},{"key":"5070_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s43556-024-00219-6","volume":"5","author":"HJ Harris","year":"2024","unstructured":"Harris HJ, \u0141aniewski P, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer. Mol Biomed. 2024;5:55.","journal-title":"Mol Biomed"},{"key":"5070_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE, \u0141aniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675\u201390.","journal-title":"EBioMedicine"},{"key":"5070_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105064","volume":"102","author":"K Njoku","year":"2024","unstructured":"Njoku K, Pierce A, Chiasserini D, Geary B, Campbell AE, Kelsall J, et al. Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery. EBioMedicine. 2024;102:105064.","journal-title":"EBioMedicine"},{"key":"5070_CR33","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.3390\/ijms23095266","volume":"23","author":"C Stoica","year":"2022","unstructured":"Stoica C, Ferreira AK, Hannan K, Bakovic M. Bilayer forming phospholipids as targets for cancer therapy. Int J Mol Sci. 2022;23:5266.","journal-title":"Int J Mol Sci"},{"key":"5070_CR34","doi-asserted-by":"publisher","first-page":"35541","DOI":"10.18632\/oncotarget.26222","volume":"9","author":"A Sorvina","year":"2018","unstructured":"Sorvina A, Bader CA, Caporale C, Carter EA, Johnson IRD, Parkinson-Lawrence EJ, et al. Lipid profiles of prostate cancer cells. Oncotarget. 2018;9:35541\u201352.","journal-title":"Oncotarget"},{"key":"5070_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86794-2","volume":"15","author":"Y Ma","year":"2025","unstructured":"Ma Y, Wu F, Yu Z, Yang L. Evaluating the association between lipidome and female reproductive diseases through comprehensive Mendelian randomization analyses. Sci Rep. 2025;15:2448.","journal-title":"Sci Rep"},{"key":"5070_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97505-y","volume":"11","author":"A Skorupa","year":"2021","unstructured":"Skorupa A, Ponski M, Ciszek M, Cichon B, Klimek M, Witek A, et al. Grading of endometrial cancer using (1)H HR-MAS NMR-based metabolomics. Sci Rep. 2021;11:18160.","journal-title":"Sci Rep"},{"key":"5070_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118095","volume":"187","author":"D Delmas","year":"2025","unstructured":"Delmas D, Mialhe A, Cotte AK, Connat JL, Bouyer F, Hermetet F, et al. Lipid metabolism in cancer: Exploring phospholipids as potential biomarkers. Biomed Pharmacother. 2025;187:118095.","journal-title":"Biomed Pharmacother"},{"key":"5070_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12944-024-02121-0","volume":"23","author":"Y Takanashi","year":"2024","unstructured":"Takanashi Y, Kahyo T, Sekihara K, Kawase A, Setou M, Funai K. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies. Lipids Health Dis. 2024;23:154.","journal-title":"Lipids Health Dis"},{"key":"5070_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12944-021-01512-x","volume":"20","author":"A Pakiet","year":"2021","unstructured":"Pakiet A, Sikora K, Kobiela J, Rostkowska O, Mika A, Sledzinski T. Alterations in complex lipids in tumor tissue of patients with colorectal cancer. Lipids Health Dis. 2021;20:85.","journal-title":"Lipids Health Dis"},{"key":"5070_CR40","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.3390\/ijms26104472","volume":"26","author":"AU B\u0142achnio-Zabielska","year":"2025","unstructured":"B\u0142achnio-Zabielska AU, Sadowska P, Chlabicz U, Pogodzi\u0144ska K, Le Stunff H, Lauda\u0144ski P, et al. Differential effects of sphingolipids on cell death and antioxidant defenses in type 1 and type 2 endometrial cancer cells. Int J Mol Sci. 2025;26:4472.","journal-title":"Int J Mol Sci"},{"key":"5070_CR41","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/cancers13040718","volume":"13","author":"K Njoku","year":"2021","unstructured":"Njoku K, Campbell AE, Geary B, MacKintosh ML, Derbyshire AE, Kitson SJ, et al. Metabolomic biomarkers for the detection of obesity-driven endometrial cancer. Cancers (Basel). 2021;13:718.","journal-title":"Cancers (Basel)"},{"key":"5070_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fendo.2018.00087","volume":"9","author":"Y Audet-Delage","year":"2018","unstructured":"Audet-Delage Y, Villeneuve L, Gregoire J, Plante M, Guillemette C. Identification of metabolomic biomarkers for endometrial cancer and its recurrence after surgery in postmenopausal women. Front Endocrinol (Lausanne). 2018;9:87.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5070_CR43","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1021\/acs.jproteome.3c00226","volume":"22","author":"OO Bifarin","year":"2023","unstructured":"Bifarin OO, Sah S, Gaul DA, Moore SG, Chen R, Palaniappan M, et al. Machine learning reveals lipidome remodeling dynamics in a mouse model of ovarian cancer. J Proteome Res. 2023;22:2092\u2013108.","journal-title":"J Proteome Res"},{"key":"5070_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cca.2018.02.029","volume":"481","author":"N Kozar","year":"2018","unstructured":"Kozar N, Kruusmaa K, Bitenc M, Argamasilla R, Adsuar A, Goswami N, et al. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer. Clin Chim Acta. 2018;481:108\u201314.","journal-title":"Clin Chim Acta"},{"key":"5070_CR45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.37349\/etat.2023.00185","volume":"4","author":"Y Li","year":"2023","unstructured":"Li Y, Karin M, Prochownik EV. Cholesterol esterification and p53-mediated tumor suppression. Explor Target Antitumor Ther. 2023;4:1122\u20137.","journal-title":"Explor Target Antitumor Ther"},{"key":"5070_CR46","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3390\/ijms24032116","volume":"24","author":"AM Mustonen","year":"2023","unstructured":"Mustonen AM, Nieminen P. Dihomo-\u03b3-Linolenic Acid (20:3n-6)-Metabolism, derivatives, and potential significance in chronic inflammation. Int J Mol Sci. 2023;24:2116.","journal-title":"Int J Mol Sci"},{"key":"5070_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97644-6","volume":"15","author":"D Wu","year":"2025","unstructured":"Wu D, Fan F, He J, Wang L, Zhu C, Ji Y, et al. Effects of polyunsaturated fatty acids on gastric cancer immunity and immunotherapy. Sci Rep. 2025;15:19891.","journal-title":"Sci Rep"},{"key":"5070_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2025.102684","volume":"205","author":"DWT Nilsen","year":"2025","unstructured":"Nilsen DWT, Aarsetoey H, Poenitz V, Brugger-Andersen T, Harris WS, Staines H, et al. Dihomo-gamma-linolenic acid (DGLA) is inversely related to risk for cardiac death and cardiovascular events during 2 years follow-up after admission for an acute coronary syndrome. Prostaglandins Leukot Essent Fatty Acids. 2025;205:102684.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"5070_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2016.04.020","volume":"785","author":"S Sergeant","year":"2016","unstructured":"Sergeant S, Rahbar E, Chilton FH. Gamma-linolenic acid, Dihommo-gamma linolenic, eicosanoids and inflammatory processes. Eur J Pharmacol. 2016;785:77\u201386.","journal-title":"Eur J Pharmacol"},{"key":"5070_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.molcel.2019.09.008","volume":"76","author":"R Riscal","year":"2019","unstructured":"Riscal R, Skuli N, Simon MC. Even cancer cells watch their cholesterol! Mol Cell. 2019;76:220\u201331.","journal-title":"Mol Cell"},{"key":"5070_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8848161","volume":"2021","author":"AH Mariamenatu","year":"2021","unstructured":"Mariamenatu AH, Abdu EM. Overconsumption of Omega-6 Polyunsaturated Fatty Acids (PUFAs) versus deficiency of Omega-3 PUFAs in modern-day diets: The disturbing factor for their \u201cBalanced Antagonistic Metabolic Functions\u201d in the human body. J Lipids. 2021;2021:8848161.","journal-title":"J Lipids"},{"key":"5070_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.mce.2015.07.008","volume":"413","author":"T Yoda","year":"2015","unstructured":"Yoda T, Kikuchi K, Miki Y, Onodera Y, Hata S, Takagi K, et al. 11beta-Prostaglandin F2alpha, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer. Mol Cell Endocrinol. 2015;413:236\u201347.","journal-title":"Mol Cell Endocrinol"},{"key":"5070_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/foods14010046","volume":"14","author":"M Mititelu","year":"2025","unstructured":"Mititelu M, Lupuliasa D, Neacsu SM, Olteanu G, Busnatu SS, Mihai A, et al. Polyunsaturated fatty acids and human health: a key to modern nutritional balance in association with polyphenolic compounds from food sources. Foods. 2025;14:46.","journal-title":"Foods"},{"key":"5070_CR54","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/1873-3468.12825","volume":"591","author":"D Hishikawa","year":"2017","unstructured":"Hishikawa D, Valentine WJ, Iizuka-Hishikawa Y, Shindou H, Shimizu T. Metabolism and functions of docosahexaenoic acid-containing membrane glycerophospholipids. FEBS Lett. 2017;591:2730\u201344.","journal-title":"FEBS Lett"},{"key":"5070_CR55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/nu2030355","volume":"2","author":"PC Calder","year":"2010","unstructured":"Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2:355\u201374.","journal-title":"Nutrients"},{"key":"5070_CR56","first-page":"330","volume":"16","author":"IA Clim","year":"2026","unstructured":"Clim IA, Faur IF, Prodan-Barbulescu C, Neamtu AA, Pasca P, Burta C, et al. Fats and facts: a meta-analysis of lipid biomarkers in endometrial cancer. Life (Basel). 2026;16:330.","journal-title":"Life (Basel)"},{"key":"5070_CR57","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1677\/ERC-07-0132","volume":"14","author":"AE Cust","year":"2007","unstructured":"Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjonneland A, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2007;14:755\u201367.","journal-title":"Endocr Relat Cancer"},{"key":"5070_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.steroids.2014.01.013","volume":"83","author":"M Chen","year":"2014","unstructured":"Chen M, Penning TM. 5beta-Reduced steroids and human Delta(4)-3-ketosteroid 5beta-reductase (AKR1D1). Steroids. 2014;83:17\u201326.","journal-title":"Steroids"},{"key":"5070_CR59","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1053\/j.gastro.2021.05.009","volume":"161","author":"J Ecker","year":"2021","unstructured":"Ecker J, Benedetti E, Kindt ASD, Horing M, Perl M, Machmuller AC, et al. The colorectal cancer lipidome: identification of a robust tumor-specific lipid species signature. Gastroenterology. 2021;161:910\u201323 e919.","journal-title":"Gastroenterology"},{"key":"5070_CR60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41420-023-01493-z","volume":"9","author":"Y Jin","year":"2023","unstructured":"Jin Y, Tan Y, Wu J, Ren Z. Lipid droplets: a cellular organelle vital in cancer cells. Cell Death Discov. 2023;9:254.","journal-title":"Cell Death Discov"},{"key":"5070_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02175-5","volume":"21","author":"K Xiong","year":"2021","unstructured":"Xiong K, Wang G, Peng T, Zhou F, Chen S, Liu W, et al. The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer. Cancer Cell Int. 2021;21:461.","journal-title":"Cancer Cell Int"},{"key":"5070_CR62","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.2147\/IJWH.S468733","volume":"16","author":"C Dang","year":"2024","unstructured":"Dang C, Wang X, Liu P, Liu J, Yu X. Genetically proxied therapeutic effect of lipid-lowering drugs use, breast cancer, and endometrial cancer\u2019s risk: a drug target-based mendelian randomization study. Int J Womens Health. 2024;16:2033\u201341.","journal-title":"Int J Womens Health"},{"key":"5070_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1446457","volume":"15","author":"Z Yang","year":"2024","unstructured":"Yang Z, Chen J, Wen M, Lei J, Zeng M, Li S, et al. Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study. Front Endocrinol (Lausanne). 2024;15:1446457.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5070_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107785","volume":"300","author":"L Sun","year":"2024","unstructured":"Sun L, Meng H, Liu T, Zhao Q, Xia M, Zhao Z, et al. Nucleolin malonylation as a nuclear-cytosol signal exchange mechanism to drive cell proliferation in Hepatocarcinoma by enhancing AKT translation. J Biol Chem. 2024;300:107785.","journal-title":"J Biol Chem"},{"key":"5070_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4568-2","volume":"18","author":"T Lofterod","year":"2018","unstructured":"Lofterod T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, et al. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 2018;18:654.","journal-title":"BMC Cancer"},{"key":"5070_CR66","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3390\/ijms26073322","volume":"26","author":"Y Razghonova","year":"2025","unstructured":"Razghonova Y, Mika A, Czapiewska M, Stanczak A, Zygowska P, Wydra DG, et al. Endometrial cancer is associated with altered metabolism and composition of fatty acids. Int J Mol Sci. 2025;26:3322.","journal-title":"Int J Mol Sci"},{"key":"5070_CR67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12944-023-01868-2","volume":"22","author":"W Li","year":"2023","unstructured":"Li W, Xu Y, Zeng X, Tan J, Wang Y, Wu H, et al. Etiological relationship between lipid metabolism and endometrial carcinoma. Lipids Health Dis. 2023;22:116.","journal-title":"Lipids Health Dis"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05070-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05070-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05070-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:02:29Z","timestamp":1792501349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05070-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5070"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05070-w","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at the University of Arizona (reference no. 1708726047) and all women provided written informed consent to participate. The study was conducted in accordance with federal guidelines and regulations and the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MMH-K and P\u0141 have a pending patent for Predictive and Diagnostic Screening Methods for Endometrial Cancer. The other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"576"}}